miR-122 and miR-21 are Stable Components of miRNA Signatures of Early Lung Cancer after Validation in Three Independent Cohorts
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-122 and miR-21 are Stable Components of miRNA Signatures of Early Lung Cancer after Validation in Three Independent Cohorts
Authors
Keywords
-
Journal
JOURNAL OF MOLECULAR DIAGNOSTICS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-10-20
DOI
10.1016/j.jmoldx.2023.09.010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-122 in human cancers: from mechanistic to clinical perspectives
- (2023) Mahboobeh Faramin Lashkarian et al. Cancer Cell International
- MicroRNA-21 as a diagnostic and prognostic biomarker of lung cancer: a systematic review and meta-analysis
- (2022) Wei Wang et al. BIOSCIENCE REPORTS
- Serum Exosomes and Their miRNA Load—A Potential Biomarker of Lung Cancer
- (2021) Mateusz Smolarz et al. Cancers
- Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
- (2020) Harry J. de Koning et al. NEW ENGLAND JOURNAL OF MEDICINE
- MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers
- (2020) Omid Kooshkaki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Up-Regulation of FSTL3, Regulated by lncRNA DSCAM-AS1/miR-122-5p Axis, Promotes Proliferation and Migration of Non-Small Cell Lung Cancer Cells
- (2020) Liang Gao et al. OncoTargets and Therapy
- Biomarkers for lung cancer screening and detection
- (2020) Edwin J. Ostrin et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Molecular comparison of interval and screen-detected breast cancers
- (2019) Dane Cheasley et al. JOURNAL OF PATHOLOGY
- Serum and blood based biomarkers for lung cancer screening: a systematic review
- (2018) Gavin C. W. Chu et al. BMC CANCER
- miRNAs as biomarkers and for the early detection of non-small cell lung cancer (NSCLC)
- (2018) Yichao Han et al. Journal of Thoracic Disease
- Involvement of dual-strand of the miR-144 duplex and their targets in the pathogenesis of lung squamous cell carcinoma
- (2018) Akifumi Uchida et al. CANCER SCIENCE
- Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape
- (2017) Hawazin Faruki et al. Journal of Thoracic Oncology
- Progress and prospects of early detection in lung cancer
- (2017) Sean Blandin Knight et al. Open Biology
- Screening and Early Detection of Lung Cancer
- (2017) Julia A. Eggert et al. Seminars in Oncology Nursing
- Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer
- (2016) Qingyun Liu et al. Oncotarget
- Circulating Cancer Biomarkers: The Macro-revolution of the Micro-RNA
- (2016) Francesca Montani et al. EBioMedicine
- MiR-122 Induces Radiosensitization in Non-Small Cell Lung Cancer Cell Line
- (2015) Debin Ma et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- miR-Test: A Blood Test for Lung Cancer Early Detection
- (2015) Francesca Montani et al. JNCI-Journal of the National Cancer Institute
- Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers
- (2015) Tomasz Powrózek et al. Translational Research
- miR-Test: A Blood Test for Lung Cancer Early Detection
- (2015) Francesca Montani et al. JNCI-Journal of the National Cancer Institute
- Circulating MicroRNAs as Non-Invasive Biomarkers for Early Detection of Non-Small-Cell Lung Cancer
- (2015) Magdalena B. Wozniak et al. PLoS One
- Clinical Utility of a Plasma-Based miRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study
- (2014) Gabriella Sozzi et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnostic work-up and surgery in participants of the Gdansk lung cancer screening programme: the incidence of surgery for non-malignant conditions
- (2013) Witold Rzyman et al. Interactive Cardiovascular and Thoracic Surgery
- A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer
- (2011) Fabrizio Bianchi et al. EMBO Molecular Medicine
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now